Description of Ertugliflozin L-pyroglutamic acid from Watson Biotechnology Co., Ltd

Specifications(COA) of Ertugliflozin L-pyroglutamic acid CAS 1210344-83-4

Ertugliflozin L-pyroglutamic acid is a pharmaceutical compound used as an anti-diabetic medication. It is an inhibitor of the sodium-glucose co-transporter 2 (SGLT2), which plays a key role in the reabsorption of glucose in the kidneys. The primary application of Ertugliflozin L-pyroglutamic acid is in the management of type 2 diabetes mellitus.

### Key Applications:

1. **Blood Glucose Control**: Ertugliflozin helps lower blood glucose levels by inhibiting SGLT2, reducing glucose reabsorption in the kidneys, and increasing glucose excretion in the urine.

2. **Weight Management**: By promoting glucose excretion, it can also contribute to weight loss, which is beneficial for patients with type 2 diabetes.

3. **Cardiovascular Benefits**: Studies suggest that SGLT2 inhibitors like Ertugliflozin may offer cardiovascular benefits, such as reducing the risk of heart failure in patients with type 2 diabetes.

4. **Renal Protection**: It may also have protective effects on the kidneys, reducing the progression of diabetic kidney disease.

Ertugliflozin is typically used as part of a broader treatment plan for type 2 diabetes, which may include diet, exercise, and other medications.

Founded in 2006 and headquartered in Wuhan, Hubei, China, Watson Biotechnology Co., Ltd is a leading manufacturing powerhouse specializing in the production of Active Pharmaceutical Ingredients (APIs) and Intermediates, Food and Feed Additives, Agricultural and Aquaculture chemicals, and Fine Chemicals. As a dedicated factory, our operations are driven by a commitment to excellence and innovation, ensuring that our products meet the highest standards of quality and compliance.

With a robust team of over 100 skilled professionals, Watson Biotechnology has established itself as a trusted name in the industry. Our products are meticulously crafted to align with international standards such as USP (United States Pharmacopeia), EP (European Pharmacopoeia), and BP (British Pharmacopoeia), guaranteeing reliability and efficacy.

At Watson Biotechnology, we pride ourselves on our cutting-edge facilities and state-of-the-art technology, which enable us to deliver superior products that cater to a diverse range of needs across various sectors. Our dedication to continuous improvement and customer satisfaction drives us to maintain stringent quality control processes and foster an environment of innovation and growth.

Watson Biotechnology Co., Ltd is a professional manufacturer which provide Ertugliflozin L-pyroglutamic acid with good quality and best price, welcome to contact us to get COA/TDS/MSDS of Ertugliflozin L-pyroglutamic acid.